[Ovulation inhibition with low dosage gestagen components. Results of international clinical trial of Orlest].
D000085:Acetates / Q000008:administration & dosage / Q000494:pharmacology; D000328:Adult; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D003864:Depression, Chemical; D004717:Endometrium / Q000187:drug effects; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005298:Fertility / Q000187:drug effects; D006801:Humans; D009640:Norethindrone / Q000008:administration & dosage / Q000494:pharmacology*; D010060:Ovulation / Q000187:drug effects*; D011247:Pregnancy; D011276:Pregnanediol / Q000652:urine
D000085:Acetates; D003276:Contraceptives, Oral; D004997:Ethinyl Estradiol; D011276:Pregnanediol; D009640:Norethindrone
Ovulationshemmung mit niedrigdosierter Gestagenkomponente. Ergebnis einer internationalen klinischen Prüfung von Orlest.